LUNAR: a randomized phase 2 study of 177 Lutetium-PSMA neoadjuvant to ablative radiotherapy for oligorecurrent prostate cancer (clinical trial protocol).

Ting Martin MaJohannes CzerninCarol FelixRejah AlanoHolly WilhalmeLuca ValleMichael L SteinbergMagnus DahlbomRobert E ReiterMatthew B RettigMinsong CaoJeremie CalaisAmar U Kishan

Published in: BJU international (2023)

Lu-PNT2002 to SBRT in patients with oligorecurrent mHSPC.

Keyphrases

locally advanced
prostate cancer
radiation therapy
clinical trial
open label
rectal cancer
double blind
pet ct
radical prostatectomy
randomized controlled trial
phase ii
squamous cell carcinoma
early stage
pet imaging
radiation induced
lymph node
study protocol
placebo controlled
phase iii